# Velynxia AI Media Suite - Phase 9 GitHub Issue

Date: 2026-06-27

## Issue 9 - Phase 9: Specialized AI Agents

Title:
Phase 9 - Specialized Agent Runtime and Tooling

Labels:
agents, ai-platform, orchestration, phase-9, priority-medium

Assignees (suggested):
- Owner: AI Platform Lead
- Support: LLM Engineer
- Support: Frontend Lead

Body:

### Objective
Launch role-specific agents with controlled tool access, task handoff, and traceable execution.

### Scope
- Agent runtime and profile definitions.
- Tool registry and permission matrix.
- Agent handoff protocol.
- Safety guardrails and auditability.

### Engineering checklist
- [ ] Implement agent runtime abstraction for multi-step tasks.
- [ ] Define initial agent profiles:
  - [ ] Sales Agent
  - [ ] Marketing Agent
  - [ ] SEO Agent
  - [ ] Support Agent
- [ ] Implement tool registry and per-agent authorization rules.
- [ ] Add inter-agent handoff with context packaging.
- [ ] Add output guardrails and restricted-content filters.
- [ ] Add detailed trace logs for agent plans, tool calls, and outcomes.
- [ ] Add integration tests for representative agent scenarios.

### Acceptance criteria
- [ ] Each agent completes at least one end-to-end use case successfully.
- [ ] Unauthorized tool calls are blocked and logged.
- [ ] Handoff between agents preserves required context.
- [ ] Guardrails prevent restricted output classes.
- [ ] Agent traces are queryable for debugging and review.

### Non-functional requirements
- [ ] Agent execution latency and success rate metrics published.
- [ ] Rate limiting prevents runaway tool loops.
- [ ] Incident playbook exists for agent misuse or regression.

### Dependencies
- Phases 2, 7, and 8 foundations.
- Tool APIs and connector stability.

### Risks
- Tool misuse due to insufficient permission granularity.
- Hallucinated action sequences creating operational risk.

### Definition of done
- [ ] Minimum 4 production agents enabled behind feature flags.
- [ ] CI includes agent behavior regression tests.
- [ ] Production rollout with controlled cohort completed.
